{"id":"placebo-one-of-medication","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo expectation)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo works by activating the patient's expectation of benefit, which can trigger real neurobiological changes including endogenous opioid release, dopamine activation, and modulation of pain perception and symptom severity. This effect is particularly pronounced in conditions with subjective symptom components such as pain, nausea, fatigue, and anxiety, though it can also produce measurable physiological changes in some objective parameters.","oneSentence":"Placebo produces therapeutic effects through patient expectation and the psychobiological placebo response, rather than through a pharmacologically active ingredient.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:25.201Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Used as control comparator in clinical trials across multiple therapeutic areas"}]},"trialDetails":[{"nctId":"NCT07494305","phase":"PHASE2","title":"Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.","status":"RECRUITING","sponsor":"LB Pharmaceuticals Inc.","startDate":"2026-01-23","conditions":"Bipolar I Disorder","enrollment":320},{"nctId":"NCT05377424","phase":"PHASE1, PHASE2","title":"Adenosine 2A Receptor Antagonism and AIH in ALS","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-06-21","conditions":"ALS","enrollment":40},{"nctId":"NCT07072468","phase":"PHASE2","title":"Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)","status":"RECRUITING","sponsor":"VM Therapeutics LLC","startDate":"2025-12-12","conditions":"Chemotherapy-induced Peripheral Neuropathy, Drug-Induced Nephropathy","enrollment":16},{"nctId":"NCT06439082","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-10-24","conditions":"Sickle Cell Disease","enrollment":315},{"nctId":"NCT06280235","phase":"PHASE2","title":"A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-03-27","conditions":"Depressive Disorder, Major","enrollment":243},{"nctId":"NCT07492160","phase":"PHASE2","title":"Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms","status":"RECRUITING","sponsor":"Maimonides Medical Center","startDate":"2026-03-16","conditions":"Pregnancy, Abortion","enrollment":348},{"nctId":"NCT07339774","phase":"PHASE2","title":"Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-30","conditions":"Radiotherapy-induced Oral Mucositis","enrollment":128},{"nctId":"NCT04149210","phase":"PHASE3","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-08-19","conditions":"Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases","enrollment":2410},{"nctId":"NCT06217302","phase":"PHASE3","title":"Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease","status":"RECRUITING","sponsor":"Alessandro Doria","startDate":"2024-10-31","conditions":"Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1","enrollment":150},{"nctId":"NCT07236190","phase":"PHASE1, PHASE2","title":"Biomarker-based Trial of NPC-1 for Alzheimer's Pathology","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03","conditions":"Alzheimer Disease, Mild Cognitive Impairment (MCI), Subjective Cognitive Complaints (SCCs)","enrollment":40},{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT07384052","phase":"PHASE1","title":"Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2026-02-20","conditions":"Spinal Cord Injury","enrollment":12},{"nctId":"NCT06652737","phase":"PHASE1","title":"Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanaria Inc.","startDate":"2025-03-04","conditions":"Malaria Falciparum, Malaria Infection","enrollment":75},{"nctId":"NCT05430152","phase":"PHASE2","title":"Low-dose Naltrexone for Post-COVID Fatigue Syndrome","status":"COMPLETED","sponsor":"Luis Nacul","startDate":"2024-01-15","conditions":"Post-Viral Fatigue Syndrome","enrollment":160},{"nctId":"NCT07481630","phase":"PHASE3","title":"A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain","status":"NOT_YET_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-04-13","conditions":"Obesity, Knee Osteoarthritis (OA)","enrollment":400},{"nctId":"NCT06451120","phase":"PHASE2","title":"Platelet Rich Plasma Injections In Young And Old Human Subjects","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-06-01","conditions":"Osteoarthritis, Articular Cartilage, Musculoskeletal Disorders","enrollment":60},{"nctId":"NCT07483346","phase":"PHASE1","title":"IASO-782 in Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IASO Biotechnology Co., Ltd","startDate":"2026-04-30","conditions":"SLE - Systemic Lupus Erythematosus","enrollment":20},{"nctId":"NCT03844412","phase":"PHASE2","title":"Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments","status":"COMPLETED","sponsor":"Duke University","startDate":"2019-11-04","conditions":"Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome","enrollment":209},{"nctId":"NCT02720094","phase":"PHASE2, PHASE3","title":"Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12-19","conditions":"HIV Infections","enrollment":4570},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT07426640","phase":"NA","title":"Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation","status":"COMPLETED","sponsor":"Al Mouwasat Hospital","startDate":"2021-11-01","conditions":"Premature (Early) Ejaculation","enrollment":150},{"nctId":"NCT03537742","phase":"PHASE2","title":"Cardiac Allograft Vasculopathy Inhibition With Alirocumab","status":"COMPLETED","sponsor":"Stanford University","startDate":"2019-05-13","conditions":"Vasculopathy","enrollment":114},{"nctId":"NCT07475546","phase":"PHASE3","title":"Combination Gerotherapeutic Interventions for Healthspan Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"AgelessRx","startDate":"2025-07-23","conditions":"Healthspan Improvement, Aging, Longevity","enrollment":30},{"nctId":"NCT06871488","phase":"PHASE4","title":"Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-03-05","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity, Irritability, Aggression Childhood","enrollment":136},{"nctId":"NCT06454669","phase":"PHASE2","title":"Dronabinol as an Adjunct for Reducing Pain","status":"RECRUITING","sponsor":"Christopher D. Verrico","startDate":"2024-06-15","conditions":"Low Back Pain, Chronic Pain, Back Injuries","enrollment":75},{"nctId":"NCT04145674","phase":"PHASE2","title":"A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo","status":"SUSPENDED","sponsor":"Mauro Manconi","startDate":"2022-10-22","conditions":"Restless Legs Syndrome","enrollment":50},{"nctId":"NCT06834997","phase":"PHASE2","title":"Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2026-04-01","conditions":"Endometriosis, Endometriosis Related Pain, Endometriosis, Pain","enrollment":""},{"nctId":"NCT06511063","phase":"PHASE2","title":"Antiviral Clinical Trial for Long Covid-19","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-10-01","conditions":"Long Covid","enrollment":90},{"nctId":"NCT06608277","phase":"PHASE2","title":"Ketamine, SGB and Combination Treatment for TBI","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2025-07-02","conditions":"Posttraumatic Headache, Posttraumatic Stress Disorder","enrollment":175},{"nctId":"NCT07400107","phase":"PHASE3","title":"AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight","status":"NOT_YET_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-05-20","conditions":"Obesity, Overweight, Diabetes Mellitus, Type 2","enrollment":1000},{"nctId":"NCT07463378","phase":"PHASE1","title":"Study of LUT017 Gel to Improve Healing of Skin Wounds After Removal of Benign Lesions in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Antoni Ribas","startDate":"2026-04","conditions":"Wound Healing, Acute Skin Wounds","enrollment":9},{"nctId":"NCT04895358","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-06-18","conditions":"Breast Neoplasms","enrollment":340},{"nctId":"NCT03811561","phase":"PHASE3","title":"A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2019-05-08","conditions":"Diabetes Mellitus, Type 2","enrollment":1500},{"nctId":"NCT07459959","phase":"PHASE1, PHASE2","title":"LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-06-01","conditions":"Alzheimer s Disease","enrollment":40},{"nctId":"NCT04314531","phase":"PHASE3","title":"Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2020-07-01","conditions":"Active Psoriatic Arthritis","enrollment":296},{"nctId":"NCT07462715","phase":"PHASE4","title":"Statins Against Bushfire Smoke","status":"NOT_YET_RECRUITING","sponsor":"Menzies Institute for Medical Research","startDate":"2026-05-01","conditions":"Healthy Adults","enrollment":100},{"nctId":"NCT07450430","phase":"PHASE3","title":"Optimal Timing of Ketamine Initiation for SCD Pain","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-02","conditions":"Sickle Cell Disease, Sickle Cell Crisis","enrollment":90},{"nctId":"NCT06971731","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)","status":"RECRUITING","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2025-10-20","conditions":"Phenylketonuria","enrollment":120},{"nctId":"NCT06440252","phase":"PHASE3","title":"Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults","status":"COMPLETED","sponsor":"RDC Clinical Pty Ltd","startDate":"2024-10-31","conditions":"Circulatory; Change","enrollment":35},{"nctId":"NCT05503264","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-09-27","conditions":"NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis","enrollment":152},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT00409435","phase":"PHASE2","title":"A Study of Pyridostigmine in Postural Tachycardia Syndrome","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2006-10","conditions":"Postural Tachycardia Syndrome","enrollment":50},{"nctId":"NCT06575075","phase":"PHASE1, PHASE2","title":"Pilot Study of RR-HNK in OCD","status":"RECRUITING","sponsor":"Carolyn Rodriguez","startDate":"2026-01-23","conditions":"Obsessive-Compulsive Disorder","enrollment":45},{"nctId":"NCT07229911","phase":"PHASE1","title":"A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-01-07","conditions":"Healthy Volunteers, Primary Sclerosing Cholangitis","enrollment":134},{"nctId":"NCT07221240","phase":"PHASE1","title":"Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis","status":"RECRUITING","sponsor":"PRG Science & Technology Co., Ltd.","startDate":"2025-10-01","conditions":"Amyotrophic Lateral Sclerosis","enrollment":48},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT06372249","phase":"PHASE2","title":"A Clinical Trial of Soluble Fiber for Asthma","status":"RECRUITING","sponsor":"Phoenix Children's Hospital","startDate":"2025-11-10","conditions":"Asthma in Children","enrollment":105},{"nctId":"NCT07339423","phase":"PHASE3","title":"AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-02-24","conditions":"Obesity","enrollment":1150},{"nctId":"NCT05304715","phase":"PHASE2","title":"Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2022-04-13","conditions":"Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome","enrollment":44},{"nctId":"NCT06992427","phase":"PHASE3","title":"High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer","status":"RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2025-06-05","conditions":"Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8","enrollment":228},{"nctId":"NCT05894239","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2023-09-08","conditions":"Metastatic Breast Cancer","enrollment":230},{"nctId":"NCT07318480","phase":"NA","title":"Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2026-02-25","conditions":"Cocaine Use Disorder, Cocaine Dependence, Substance Use Disorder (SUD)","enrollment":120},{"nctId":"NCT06556277","phase":"NA","title":"Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake","status":"COMPLETED","sponsor":"Eleonora Seelig","startDate":"2024-09-01","conditions":"Glucocorticoids, Overweight and Obesity, Overeating","enrollment":23},{"nctId":"NCT05869812","phase":"PHASE2","title":"Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-05-29","conditions":"Atrophy","enrollment":30},{"nctId":"NCT06795776","phase":"PHASE3","title":"Eschscholzia Study","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2025-04-07","conditions":"Sleep","enrollment":104},{"nctId":"NCT05301608","phase":"PHASE1, PHASE2","title":"Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-03-03","conditions":"Healthy","enrollment":30},{"nctId":"NCT06395688","phase":"PHASE1","title":"Drug-Drug Interaction Between THC and AEF0117","status":"WITHDRAWN","sponsor":"Aelis Farma","startDate":"2025-12","conditions":"Cannabis Abuse","enrollment":""},{"nctId":"NCT06287580","phase":"EARLY_PHASE1","title":"Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension.","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-08-15","conditions":"Essential Hypertension, Older Adults","enrollment":27},{"nctId":"NCT06177535","phase":"NA","title":"A Study of Oral Kavalactones Effect on Nurses","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-08-05","conditions":"Stress","enrollment":200},{"nctId":"NCT03016819","phase":"PHASE3","title":"Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)","status":"RECRUITING","sponsor":"Advenchen Laboratories, LLC","startDate":"2017-08-15","conditions":"Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma","enrollment":325},{"nctId":"NCT07434492","phase":"PHASE2","title":"Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy","status":"NOT_YET_RECRUITING","sponsor":"Shirley Ryan AbilityLab","startDate":"2026-03-01","conditions":"Cerebral Palsy","enrollment":60},{"nctId":"NCT07432529","phase":"PHASE3","title":"Design and Rationale of the COLT Study","status":"NOT_YET_RECRUITING","sponsor":"Azienda Sanitaria Locale ASL 6, Livorno","startDate":"2026-06-01","conditions":"Venous Thrombosis Deep (Limbs), Post-thrombotic Syndrome, Venous Thromboembolism (VTE)","enrollment":940},{"nctId":"NCT07431775","phase":"","title":"Saphnelo Use in Females of Child-bearing Potential","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-10-01","conditions":"Systemic Lupus Erythematosus","enrollment":26000000},{"nctId":"NCT07433452","phase":"PHASE1","title":"The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.","status":"NOT_YET_RECRUITING","sponsor":"Gabriella Gobbi","startDate":"2026-09-01","conditions":"Healthy Participants, Placebo - Control, Psilocybin","enrollment":50},{"nctId":"NCT07431476","phase":"PHASE4","title":"Brimonidine 0.33% for Rosacea-Related Facial Erythema","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2025-05-01","conditions":"Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)","enrollment":45},{"nctId":"NCT04752774","phase":"PHASE1, PHASE2","title":"A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.","status":"RECRUITING","sponsor":"Ipsen","startDate":"2021-04-29","conditions":"Spasticity","enrollment":240},{"nctId":"NCT05799755","phase":"PHASE4","title":"Myositis Interstitial Lung Disease Nintedanib Trial","status":"COMPLETED","sponsor":"Rohit Aggarwal, MD","startDate":"2023-08-01","conditions":"Myositis Associated Interstitial Lund Disease (MA-ILD)","enrollment":49},{"nctId":"NCT07025629","phase":"PHASE3","title":"Dapagliflozin for Cardio-renal Protection After ICU Discharge","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-12-02","conditions":"Heart Failure and Chronic Kidney Disease Post-ICU","enrollment":600},{"nctId":"NCT06650761","phase":"PHASE1","title":"A Phase I Study of CDX-622","status":"ACTIVE_NOT_RECRUITING","sponsor":"Celldex Therapeutics","startDate":"2024-11-01","conditions":"Healthy Participants","enrollment":85},{"nctId":"NCT06772753","phase":"PHASE1","title":"Investigation of Psychedelic Effects in Psychoactive Substances","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-02-05","conditions":"Psychedelic Effects in Healthy Volunteers","enrollment":50},{"nctId":"NCT07282756","phase":"NA","title":"Evaluation Of The Efficacy Of Subgingival Application Of Lovastatin Gel As An Adjunct To Non-Surgical Treatment Of Periodontitis In Generally Healthy Smokers And Non-Smokers Patients in Central Europe.","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-07-11","conditions":"Periodontal Diseases, Periodontitis, Periodontal Disease","enrollment":44},{"nctId":"NCT07423533","phase":"PHASE2","title":"Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2026-02","conditions":"Rheumatoid Arthritis","enrollment":450},{"nctId":"NCT02148796","phase":"PHASE2","title":"Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2017-01-01","conditions":"Asthma, Wheezing","enrollment":822},{"nctId":"NCT03866187","phase":"PHASE1, PHASE2","title":"Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2019-03-28","conditions":"Hepatitis B, Chronic","enrollment":236},{"nctId":"NCT04918719","phase":"PHASE2","title":"Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-11-02","conditions":"Acute Ischemic Stroke","enrollment":4},{"nctId":"NCT07385287","phase":"PHASE2","title":"Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults","status":"NOT_YET_RECRUITING","sponsor":"Sanaria Inc.","startDate":"2026-04-04","conditions":"Malaria (Plasmodium Falciparum)","enrollment":180},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT07417969","phase":"NA","title":"\"Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function\"","status":"RECRUITING","sponsor":"Jose J Zaragoza, MD MSc","startDate":"2025-06-01","conditions":"Urine Output Decreased","enrollment":56},{"nctId":"NCT07161843","phase":"PHASE2, PHASE3","title":"Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)","status":"NOT_YET_RECRUITING","sponsor":"Ebima Clifford Okundaye","startDate":"2026-06-30","conditions":"Acute Renal Failure (ARF), Acute Tubular Necrosis","enrollment":500},{"nctId":"NCT05259046","phase":"NA","title":"The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bispebjerg Hospital","startDate":"2022-06-21","conditions":"Coronary Artery Calcification, Arterial Stiffness","enrollment":450},{"nctId":"NCT06058520","phase":"EARLY_PHASE1","title":"Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2023-10-01","conditions":"Hidradenitis Suppurativa","enrollment":16},{"nctId":"NCT07235683","phase":"PHASE4","title":"Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-12-24","conditions":"CMV, Lung Transplant Recipient","enrollment":40},{"nctId":"NCT07395687","phase":"PHASE2","title":"A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-02-02","conditions":"Overweight, Obesity","enrollment":333},{"nctId":"NCT04491526","phase":"PHASE4","title":"Study to Prevent Postoperative Urinary Retention","status":"TERMINATED","sponsor":"Antonio Nocito, MD","startDate":"2020-11-01","conditions":"Urinary Retention, Inguinal Hernia","enrollment":312},{"nctId":"NCT04606316","phase":"PHASE1","title":"Surgical Nivolumab And Ipilimumab For Recurrent GBM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Patrick Wen, MD","startDate":"2021-02-01","conditions":"Glioblastoma, GBM, Glioblastoma Multiforme","enrollment":63},{"nctId":"NCT07415252","phase":"PHASE3","title":"SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years","status":"NOT_YET_RECRUITING","sponsor":"SK Bioscience Co., Ltd.","startDate":"2026-06-05","conditions":"Varicella (Chickenpox)","enrollment":780},{"nctId":"NCT04774250","phase":"PHASE2","title":"Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2021-11-10","conditions":"Hearing Loss, Noise-Induced","enrollment":3},{"nctId":"NCT05900336","phase":"PHASE4","title":"Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With Dysmenorrhea","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2024-03-25","conditions":"Dysmenorrhea, Menstrual Pain, Non-steroidal Anti-inflammatory Drug","enrollment":70},{"nctId":"NCT03972592","phase":"PHASE2","title":"Topical Sirolimus in Cutaneous Lymphatic Malformations","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2019-06-05","conditions":"Vascular Malformations, Lymphatic Malformation","enrollment":55},{"nctId":"NCT05954286","phase":"PHASE2","title":"PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19","status":"COMPLETED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2024-01-29","conditions":"SARS-CoV-2","enrollment":92},{"nctId":"NCT02947893","phase":"PHASE2","title":"Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2017-01","conditions":"Alzheimer's Disease","enrollment":37},{"nctId":"NCT04276259","phase":"PHASE4","title":"Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses","status":"COMPLETED","sponsor":"Marta Peciña, MD PhD","startDate":"2020-10-19","conditions":"Major Depressive Disorder, Depression","enrollment":120},{"nctId":"NCT06573970","phase":"PHASE4","title":"Atomoxetine and Executive Function in PTSD","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Posttraumatic Stress Disorder With Attention Defic","enrollment":160},{"nctId":"NCT07205250","phase":"EARLY_PHASE1","title":"Aspirin for Prevention of Stroke After Endovascular Aortic Arch Repair: a Multicenter, Double-Blind, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"The General Hospital of Western Theater Command","startDate":"2026-02-20","conditions":"Type B or Non-A Non-B Aortic Dissection;Thoracic Aortic Aneurysm","enrollment":224},{"nctId":"NCT06489548","phase":"PHASE2","title":"Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-09-16","conditions":"Dementia, Alzheimers Disease, Mild Cognitive Impairment Due to Alzheimer's Disease","enrollment":16},{"nctId":"NCT07407634","phase":"EARLY_PHASE1","title":"A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.","status":"NOT_YET_RECRUITING","sponsor":"Xi'an Xintong Pharmaceutical Research Co.,Ltd.","startDate":"2026-03-25","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":94},{"nctId":"NCT07407803","phase":"PHASE3","title":"Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas","status":"NOT_YET_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2026-02","conditions":"Plexiform Neurofibroma","enrollment":177},{"nctId":"NCT07404358","phase":"PHASE3","title":"Dalargin for Prevention of Organ Disfunction in High-Risk Abdominal Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Botkin Hospital","startDate":"2025-05-13","conditions":"Postoperative Complications, Multiple Organ Failure, Abdominal Surgery","enrollment":200},{"nctId":"NCT03527472","phase":"PHASE2","title":"Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2018-08-23","conditions":"Lupus Erythematosus, Systemic","enrollment":111},{"nctId":"NCT07390565","phase":"NA","title":"YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"LI FENG","startDate":"2026-02-17","conditions":"Extensive-stage Small Cell Lung Cancer (SCLC)","enrollment":308}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["patient in group C will receive none of medication"],"phase":"marketed","status":"active","brandName":"Placebo (one of medication)","genericName":"Placebo (one of medication)","companyName":"Chung-Ang University Hosptial, Chung-Ang University College of Medicine","companyId":"chung-ang-university-hosptial-chung-ang-university-college-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces therapeutic effects through patient expectation and the psychobiological placebo response, rather than through a pharmacologically active ingredient. Used for Used as control comparator in clinical trials across multiple therapeutic areas.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}